Jingxin Pharmaceutical (002020): Second-Quarter Performance Exceeds Expected Expected Performance

0 Comment

Jingxin Pharmaceutical (002020): Second-Quarter Performance Exceeds Expected Expected Performance The core point of view is that the report has grown rapidly, and the single-quarter performance in the second quarter exceeded expectations. The company announced the interim results report and achieved revenue of 18 in the first half. 59 ppm, an increase of 31 in ten…

This World Marriage (603369): Strong growth in national margins saves strong internal momentum

0 Comment

This World Marriage (603369): Strong growth in national margins saves strong internal momentum This report reads: The company’s semi-annual report has grown beautifully, in line with market expectations, and the rapid growth of national border series. At the same time, the rapid growth of the Nanjing Region has led to strong growth in many regions…